Younger Age and Albuminuria are Associated with Proliferative Diabetic Retinopathy and Diabetic Macular Edema in the South Indian GeNetics of DiAbeTic Retinopathy (SIGNATR) Study

被引:1
|
作者
Susarla, Gayatri [1 ]
Rizza, A. N. [2 ]
Li, Ashley [1 ]
Han, Samuel [1 ]
Khan, Rehana [2 ]
Chan, Weilin [1 ]
Lains, Ines [1 ]
Apivatthakakul, Atitaya [1 ]
Brustoski, Kim [3 ]
Khetan, Vikas [2 ]
Raman, Rajiv [2 ]
Igo, Robert P., Jr. [3 ]
Iyengar, Sudha K. [3 ]
Mathavan, Sinnakaruppan [2 ]
Sobrin, Lucia [1 ]
机构
[1] Massachusetts Eye & Ear Infirm, Harvard Med Sch, Dept Ophthalmol, Boston, MA 02114 USA
[2] Vis Res Fdn, Sankara Nethralaya, Chennai, Tamil Nadu, India
[3] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA
关键词
Diabetic retinopathy; South India; risk factors; genetics; type; 2; diabetes; RISK-FACTORS; HIGH PREVALENCE; URBAN INDIA; EPIDEMIOLOGY; POPULATION;
D O I
10.1080/02713683.2022.2091148
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The purpose of the South Indian GeNetics of DiAbeTic Retinopathy (SIGNATR) Study is to identify non-genetic and genetic risk factors associated with diabetic retinopathy (DR). This report examines the non-genetic risk factors for DR in South Indian patients. Methods: Participants with South Indian ancestry and type 2 diabetes (T2D) were included from two sources: the Sankara Nethralaya Diabetic Retinopathy and Molecular Genetics Study (SN-DREAMS) and prospective recruitment at Sankara Nethralaya affiliates. Fundus photography and optical coherence tomography (OCT) were obtained on participants. Fundus images were graded for DR severity and OCTs were graded for center-involved diabetic macular edema (ciDME). Multivariate analyses were performed using stepwise logistic regression to assess effects of the demographic and clinical factors on proliferative DR (PDR) and DME. Results: Among the 2941 participants with DR grading, participants with PDR were more likely to be younger [odds ratio (OR)=0.95], men (OR = 1.83), have a longer duration of diabetes (OR = 1.10), have a higher hemoglobin A1c (OR = 1.12), have albuminuria (OR = 5.83), have hypertension (OR = 1.69), have a higher HDL (OR = 1.02) and a lower total cholesterol (OR = 0.99) (all p < 0.05). Among the 483 participants with gradable OCT scans, participants who had ciDME were more likely to be younger (OR = 0.97), men (OR = 2.80), have a longer duration of diabetes (OR = 1.06), have lower triglycerides (OR = 0.99), and have albuminuria (OR = 3.12) (all p < 0.05). Conclusions: Younger age, male sex, longer duration of diabetes, higher HbA1c, and presence of albuminuria were identified as risk factors for PDR and DME in a South Indian population with T2D.
引用
收藏
页码:1389 / 1396
页数:8
相关论文
共 50 条
  • [21] Analysis of Vitreous Biomarkers in Proliferative Diabetic Retinopathy and Macular Edema
    Nandakumar, Namrata
    Lopez, Francisco J.
    Teague, Gianna C.
    Lashkari, Kameran
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [22] Multifocal Electroretinography in Diabetic Retinopathy and Diabetic Macular Edema
    Bearse, Marcus A., Jr.
    Ozawa, Glen Y.
    CURRENT DIABETES REPORTS, 2015, 15 (09)
  • [23] Pharmacologic therapies for diabetic retinopathy and diabetic macular edema
    Rechtman, Ehud
    Harris, Alon
    Garzozi, Hanna J.
    Ciulla, Thomas A.
    CLINICAL OPHTHALMOLOGY, 2007, 1 (04): : 383 - 391
  • [24] Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema
    Jie Ding
    Tien Yin Wong
    Current Diabetes Reports, 2012, 12 : 346 - 354
  • [25] Multifocal Electroretinography in Diabetic Retinopathy and Diabetic Macular Edema
    Marcus A. Bearse
    Glen Y. Ozawa
    Current Diabetes Reports, 2014, 14
  • [26] Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema
    Antoszyk, Andrew N.
    Tarnowski, Kathleen Wade
    Basu, Karen
    Ehrlich, Jason S.
    Haskova, Zdenka
    OPHTHALMOLOGY RETINA, 2020, 4 (10): : 1034 - 1036
  • [27] Imaging and Biomarkers in Diabetic Macular Edema and Diabetic Retinopathy
    Kwan, Changyow C.
    Fawzi, Amani A.
    CURRENT DIABETES REPORTS, 2019, 19 (10)
  • [28] Intravitreal bevacizumab for persistent macular edema with proliferative diabetic retinopathy
    Gulkilik G.
    Taskapili M.
    Kocabora S.
    Muftuoglu G.
    Demirci G.
    International Ophthalmology, 2010, 30 (6) : 697 - 702
  • [29] Enzymatic vitrectomy for diabetic retinopathy and diabetic macular edema
    Diaz-Llopis, Manuel
    Udaondo, Patricia
    Maria Millan, Jose
    Fernando Arevalo, J.
    WORLD JOURNAL OF DIABETES, 2013, 4 (06) : 319 - 323
  • [30] Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema
    Ding, Jie
    Wong, Tien Yin
    CURRENT DIABETES REPORTS, 2012, 12 (04) : 346 - 354